Tirzepatide/ cyanocobalamin 12.5mg/1mg ml 2ml vial

Tirzepatide / Cyanocobalamin 12.5 mg / 1 mg per mL – 2 mL Vial is a compounded injectable formulation combining a dual incretin receptor agonist with vitamin B12 to support glycemic control, weight management, and metabolic health. Tirzepatide 12.5 mg/mL – Tirzepatide is a dual GLP-1 and GIP receptor agonist that enhances glucose-dependent insulin secretion, reduces glucagon levels, delays gastric emptying, and promotes satiety. This dual mechanism has demonstrated significant effects on blood glucose reduction and weight loss. A 2 mL vial contains a total of 25 mg of tirzepatide. Tirzepatide is FDA-approved under the brand name Mounjaro for type 2 diabetes. Cyanocobalamin (Vitamin B12) 1 mg/mL – Vitamin B12 supports red blood cell production, neurological function, and energy metabolism, and may help mitigate fatigue or support metabolic processes during treatment. The vial contains a total of 2 mg of B12. This sterile solution is intended for subcutaneous injection in clinical or research settings. Tirzepatide has shown robust efficacy in improving glycemic control and promoting substantial weight reduction in clinical trials. Clinical outcomes and metabolic effects of tirzepatide: https://pubmed.ncbi.nlm.nih.gov/33657290/ Mechanism of GLP-1/GIP receptor agonists: https://pubmed.ncbi.nlm.nih.gov/34534432/